Correction to: Nature Biotechnology https://doi.org/10.1038/s41587-022-01249-7, published online 21 March 2022.
In the version of this article initially published, the surname of author Bryce Kadis was misspelled as Kaldis. The name has been corrected in the HTML and PDF versions of the article.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Jester, B.W., Zhao, H., Gewe, M. et al. Author Correction: Development of spirulina for the manufacture and oral delivery of protein therapeutics. Nat Biotechnol 40, 974 (2022). https://doi.org/10.1038/s41587-022-01323-0
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41587-022-01323-0
